The story of how one of the most potent and effective anti-HIV herbs, Gooseflower, is helping to curb the spread and spread of the virus.
The story begins when Dr. Kevin N. Johnson, a research fellow at the University of North Carolina School of Medicine, was given the opportunity to investigate the effectiveness of Goose-flowers treatment for the severe symptoms of the HIV-1 virus.
Johnson says his initial research revealed that Gooseflowers herbal medicine was able to kill the HIV virus in just two weeks, and he was immediately intrigued by the potential of the herbal medicine for combating the spread.
He and his team at the North Carolina Health and Human Services Research Center in Raleigh conducted a clinical trial to test the efficacy of Goos-Flowers herbal therapy in a group of HIV patients with no history of HIV infection.
In the study, the participants in the study were randomized into two groups, and the participants who received Goose Flower treatment showed no detectable viral load.
This meant that the herb’s ability to kill HIV was a complete win.
“I thought I was going to get the best results with my first study, and I got a little disappointed,” Johnson says.
“I realized, ‘I should really go to another place.’
And I got to another study, so I’m doing a second study.”
After receiving his first Goose Flowers treatment, Johnson was immediately drawn to a study published in the Journal of the American Medical Association in 2010.
In that study, Johnson and his colleagues followed over 6,000 patients diagnosed with HIV and found that Goosflowers helped prevent their virus from forming new cells.
In fact, one of Gooser’s primary benefits is that it blocks HIV from forming cells and replicating, preventing the virus from developing and replanting.
“The fact that you can kill HIV cells and kill it from replication is amazing,” Johnson explains.
“And I’m not talking about just killing the virus; you’re killing it from replicating.”
Johnson and his group believe GooseFlowers ability to prevent the HIV disease from forming, replicate and spread could lead to new therapies to fight other diseases.
For example, the herb could be used in the treatment of a wide range of conditions including cancer, psoriasis, rheumatoid arthritis and diabetes.
“This herb works really well in the prevention of the progression of these diseases, and it also has great efficacy,” Johnson said.
The research team found that the Goose flower was effective in reducing HIV levels in a range of cancer cells, including melanoma, prostate, colon and lung.
In addition, the research showed that Gooser was effective at stopping the spread to other organs.
“It was a very important finding because it shows that the compound has the ability to affect many different organs,” Johnson explained.
“And we’re finding that this compound can have a lot of potential for people who have cancer and other diseases where you need a long-term response.”
Dr. Andrew R. Bales, a medical doctor and a professor of medicine at the New York University Langone Medical Center, also believes that Goosisflowers ability as a natural anti-viral is very important.
Bales and Johnson also have some concerns about the use of Gooses herb in people who are at high risk for HIV infection, like the LGBT community.
Johnson and Bales also note that Gooses use of THC, the active ingredient in the herb, could increase the risk for serious side effects from the herb.
However, Johnson is optimistic that Goosenflowers effectiveness can be further improved by adding more research into its effectiveness in HIV.
“We know that the cannabinoids are important for controlling the virus, but it’s not known whether the cannabinoids also work against HIV,” Johnson notes.
“With the cannabis industry, we know that there’s a lot more research being done to see if it’s even effective against HIV.”
Johnson’s study was a pilot study that tested a group who were HIV positive, and they found that while the herb was effective, they didn’t see a need for it for people at high-risk of HIV.
“We don’t have data that’s going to say that it’s an ideal solution for everyone,” Johnson noted.
Dr. Joseph D. Mazzanti, director of the National Center for HIV Research, believes that it is important to keep GoosFlowers use in mind for those at high levels of HIV exposure, because it’s been shown that people who were infected with HIV were less likely to have a response to GoosFols treatment.
He adds that there is a lot that needs to be done before GoosFLowers could be a treatment for HIV patients.
In addition to Johnson’s and Mazzantis studies, the NCI is conducting studies that will look at the efficacy and safety of Goosenflower in the development